(0.12%) 5 303.27 points
(0.34%) 40 004 points
(-0.07%) 16 686 points
(0.97%) $80.00
(5.73%) $2.64
(1.44%) $2 419.80
(6.36%) $31.78
(2.18%) $1 094.70
(-0.02%) $0.920
(-0.18%) $10.68
(-0.27%) $0.787
(0.19%) $91.05
6.99% $ 4.06
@ $1.280
Emitido: 13 feb 2024 @ 09:30
Retorno: 216.80%
Señal anterior: feb 12 - 14:52
Señal anterior:
Retorno: -3.76 %
Live Chart Being Loaded With Signals
ProKidney Corp., a clinical-stage biotechnology, engages in developing cellular therapy candidates. It is developing Renal Autologous Cell Therapy, an autologous homologous cell admixture that is in a Phase III development program, as well as Phase II clinical trials for the treatment of moderate to severe diabetic kidney disease; and Phase I clinical trial for patients with congenital anomalies of the kidney and urinary tract...
Stats | |
---|---|
Volumen de hoy | 546 394 |
Volumen promedio | 774 563 |
Capitalización de mercado | 939.54M |
EPS | $0 ( 2024-05-09 ) |
Próxima fecha de ganancias | ( $-0.220 ) 2024-08-08 |
Last Dividend | $0 ( N/A ) |
Next Dividend | $0 ( N/A ) |
P/E | -7.11 |
ATR14 | $0.00700 (0.17%) |
Date | Person | Action | Amount | type |
---|---|---|---|---|
2024-03-25 | Control Empresarial De Capitales S.a. De C.v. | Buy | 30 000 | Class A Ordinary Shares (as defined in Exhibit 99.1 hereto) |
2024-03-22 | Control Empresarial De Capitales S.a. De C.v. | Buy | 14 000 | Class A Ordinary Shares (as defined in Exhibit 99.1 hereto) |
2024-03-20 | Control Empresarial De Capitales S.a. De C.v. | Buy | 33 000 | Class A Ordinary Shares (as defined in Exhibit 99.1 hereto) |
2024-03-14 | Control Empresarial De Capitales S.a. De C.v. | Buy | 50 000 | Class A Ordinary Shares (as defined in Exhibit 99.1 hereto) |
2024-03-13 | Control Empresarial De Capitales S.a. De C.v. | Buy | 50 000 | Class A Ordinary Shares (as defined in Exhibit 99.1 hereto) |
INSIDER POWER |
---|
-30.35 |
Last 98 transactions |
Buy: 21 980 380 | Sell: 30 162 499 |
Volumen Correlación
ProKidney Corp. Correlación
10 Correlaciones Más Positivas |
---|
10 Correlaciones Más Negativas |
---|
Did You Know?
Correlation is a statistical measure that describes the relationship between two variables. It ranges from -1 to 1, where -1 indicates a perfect negative correlation (as one variable increases, the other decreases), 1 indicates a perfect positive correlation (as one variable increases, the other increases), and 0 indicates no correlation (there is no relationship between the variables).
Correlation can be used to analyze the relationship between any two variables, not just stocks. It's commonly used in fields such as finance, economics, psychology, and more.
ProKidney Corp. Correlación - Moneda/Commodity
ProKidney Corp. Finanzas
Annual | 2023 |
Ingresos: | $0 |
Beneficio Bruto: | $-3.17M (0.00 %) |
EPS: | $-0.570 |
FY | 2023 |
Ingresos: | $0 |
Beneficio Bruto: | $-3.17M (0.00 %) |
EPS: | $-0.570 |
FY | 2022 |
Ingresos: | $0 |
Beneficio Bruto: | $-3.04M (0.00 %) |
EPS: | $-2.41 |
FY | 2021 |
Ingresos: | $0.00 |
Beneficio Bruto: | $0.00 (0.00 %) |
EPS: | $-0.296 |
Financial Reports:
No articles found.
Contract Name | Last Trade Date (EDT) | Strike | Last Price | Bid | Ask | Change | % Change | Volume | Open Interest | Implied Volatility | Strike Date |
---|---|---|---|---|---|---|---|---|---|---|---|
No data available |
Contract Name | Last Trade Date (EDT) | Strike | Last Price | Bid | Ask | Change | % Change | Volume | Open Interest | Implied Volatility | Strike Date |
---|---|---|---|---|---|---|---|---|---|---|---|
No data available |
ProKidney Corp.
ProKidney Corp., a clinical-stage biotechnology, engages in developing cellular therapy candidates. It is developing Renal Autologous Cell Therapy, an autologous homologous cell admixture that is in a Phase III development program, as well as Phase II clinical trials for the treatment of moderate to severe diabetic kidney disease; and Phase I clinical trial for patients with congenital anomalies of the kidney and urinary tract. The company was founded in 2015 and is headquartered in Winston-Salem, North Carolina.
Acerca de Señales en Vivo
Las señales en vivo presentadas en esta página ayudan a determinar cuándo COMPRAR o VENDER NA. Las señales tienen un retraso de más de 1 minuto; como todas las señales del mercado, existe la posibilidad de error o errores.
Las señales de trading en vivo no son definitivas y getagraph.com no asume ninguna responsabilidad por cualquier acción tomada sobre estas señales, como se describe en los Términos de Uso. Las señales se basan en una amplia gama de indicadores de análisis técnico